|

REGistry of Long-term AnTithrombotic TherApy-2

RECRUITINGSponsored by National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Actively Recruiting
SponsorNational Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Started2015-01-15
Est. completion2026-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04347187

Summary

To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with atrial fibrillation

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Documented atrial fibrillation with CHA2DS2VASC \> 1

Exclusion Criteria:

* Subjects who are unwilling or unable to provide informed consent. ACS within 12 months before inclusion Severe CHF (NYHA IV) Stroke within 6 months before inclusion Severe liver or muscle disease Severe kidney disease / renal failure with creatinine \> 3 mg/dl Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention

Conditions2

Atrial FibrillationHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.